104 related articles for article (PubMed ID: 15074584)
1. [Influence of 2-aryl-3-halogen/3-hydroxy-1,4-naphthoquinones with salicylic and cinnamic acid partial structures on the arachidonic acid cascade].
Richwien A; Wurm G
Pharmazie; 2004 Mar; 59(3):163-9. PubMed ID: 15074584
[TBL] [Abstract][Full Text] [Related]
2. [Inhibition of the arachidonic acid cascade by aza-2-aryl-1,4-naphthoquinone derivatives].
Richwien A; Wurm G
Pharmazie; 2004 Dec; 59(12):906-12. PubMed ID: 15638076
[TBL] [Abstract][Full Text] [Related]
3. [2-(3-Halogen-4-hydroxyphenyl)-1,4-napthoquinone derivatives from 2-(3,5-di-tert-butyl-4-hydroxyphenyl)-analogs, potent 5-lipoxygenase inhibitors. 27. 1,4-Naphthoquinones].
Wurm G; Schwandt S
Pharmazie; 1999 Jul; 54(7):487-90. PubMed ID: 10445242
[TBL] [Abstract][Full Text] [Related]
4. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets.
Jin YR; Cho MR; Lee KS; Lee JJ; Lim Y; Han XH; Oh KW; Hong JT; Yoo HS; Yun YP
Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):162-7. PubMed ID: 16128910
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of maesanin and analogs on arachidonic acid metabolizing enzymes.
Abourashed EA; Muhammad I; Resch M; Bauer R; el-Feraly FS; Hufford CD
Planta Med; 2001 Jun; 67(4):360-1. PubMed ID: 11458456
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of acyclic triaryl (Z)-olefins possessing a 3,5-di-tert-butyl-4-hydroxyphenyl pharmacophore: dual inhibitors of cyclooxygenases and lipoxygenases.
Moreau A; Rao PN; Knaus EE
Bioorg Med Chem; 2006 Aug; 14(15):5340-50. PubMed ID: 16677817
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of 2,3-disubstituted 1,4-naphthoquinones as antiplatelet agents.
Lien JC; Wu CR; Hour MJ; Huang LJ; Huang TF; Kuo SC
Arch Pharm (Weinheim); 2008 Oct; 341(10):639-44. PubMed ID: 18720342
[TBL] [Abstract][Full Text] [Related]
8. 1-substituted 4-aryl-5-pyridinylimidazoles: a new class of cytokine suppressive drugs with low 5-lipoxygenase and cyclooxygenase inhibitory potency.
Boehm JC; Smietana JM; Sorenson ME; Garigipati RS; Gallagher TF; Sheldrake PL; Bradbeer J; Badger AM; Laydon JT; Lee JC; Hillegass LM; Griswold DE; Breton JJ; Chabot-Fletcher MC; Adams JL
J Med Chem; 1996 Sep; 39(20):3929-37. PubMed ID: 8831759
[TBL] [Abstract][Full Text] [Related]
9. Licofelone, a dual COX/5-LOX inhibitor, induces apoptosis in HCA-7 colon cancer cells through the mitochondrial pathway independently from its ability to affect the arachidonic acid cascade.
Tavolari S; Bonafè M; Marini M; Ferreri C; Bartolini G; Brighenti E; Manara S; Tomasi V; Laufer S; Guarnieri T
Carcinogenesis; 2008 Feb; 29(2):371-80. PubMed ID: 18033773
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet activity of J78 (2-Chloro-3-[2'-bromo, 4'-fluoro-phenyl]-amino-8-hydroxy-1,4-naphthoquinone), an antithrombotic agent, is mediated by thromboxane (TX) A2 receptor blockade with TXA2 synthase inhibition and suppression of cytosolic Ca2+ mobilization.
Jin YR; Cho MR; Ryu CK; Chung JH; Yuk DY; Hong JT; Lee KS; Lee JJ; Lee MY; Lim Y; Yun YP
J Pharmacol Exp Ther; 2005 Jan; 312(1):214-9. PubMed ID: 15328379
[TBL] [Abstract][Full Text] [Related]
11. 5-Lipoxygenase inhibitors: synthesis and structure-activity relationships of a series of 1-aryl-2H,4H-tetrahydro-1,2,4-triazin-3-ones.
Bhatia PA; Brooks CD; Basha A; Ratajczyk JD; Gunn BP; Bouska JB; Lanni C; Young PR; Bell RL; Carter GW
J Med Chem; 1996 Sep; 39(20):3938-50. PubMed ID: 8831760
[TBL] [Abstract][Full Text] [Related]
12. Novel synthesis of 3,4-diarylisoxazole analogues of valdecoxib: reversal cyclooxygenase-2 selectivity by sulfonamide group removal.
Di Nunno L; Vitale P; Scilimati A; Tacconelli S; Patrignani P
J Med Chem; 2004 Sep; 47(20):4881-90. PubMed ID: 15369392
[TBL] [Abstract][Full Text] [Related]
13. Essential structural profile of a dual functional inhibitor against cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX): molecular docking and 3D-QSAR analyses on DHDMBF analogues.
Zheng M; Zhang Z; Zhu W; Liu H; Luo X; Chen K; Jiang H
Bioorg Med Chem; 2006 May; 14(10):3428-37. PubMed ID: 16458008
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of a new class of acyl derivatives of 3-amino-1-phenyl-4,5-dihydro-1H-pyrazol-5-one as potential dual cyclooxygenase (COX-1 and COX-2) and human lipoxygenase (5-LOX) inhibitors.
Cusan C; Spalluto G; Prato M; Adams M; Bodensieck A; Bauer R; Tubaro A; Bernardi P; Da Ros T
Farmaco; 2005 Apr; 60(4):327-32. PubMed ID: 15848208
[TBL] [Abstract][Full Text] [Related]
15. Hinokitiol, a selective inhibitor of the platelet-type isozyme of arachidonate 12-lipoxygenase.
Suzuki H; Ueda T; Juránek I; Yamamoto S; Katoh T; Node M; Suzuki T
Biochem Biophys Res Commun; 2000 Sep; 275(3):885-9. PubMed ID: 10973816
[TBL] [Abstract][Full Text] [Related]
16. Hydroalcoholic plant extracts with anti-inflammatory activity.
Herold A; Cremer L; Călugaru A; Tamaş V; Ionescu F; Manea S; Szegli G
Roum Arch Microbiol Immunol; 2003; 62(1-2):117-29. PubMed ID: 15493372
[TBL] [Abstract][Full Text] [Related]
17. Antiplatelet and antithrombotic activities of CP201, a newly synthesized 1,4-naphthoquinone derivative.
Jin YR; Hwang KA; Cho MR; Kim SY; Kim JH; Ryu CK; Son DJ; Park YH; Yun YP
Vascul Pharmacol; 2004 Feb; 41(1):35-41. PubMed ID: 15135330
[TBL] [Abstract][Full Text] [Related]
18. New COX-2/5-LOX inhibitors: apoptosis-inducing agents potentially useful in prostate cancer chemotherapy.
Pommery N; Taverne T; Telliez A; Goossens L; Charlier C; Pommery J; Goossens JF; Houssin R; Durant F; Hénichart JP
J Med Chem; 2004 Dec; 47(25):6195-206. PubMed ID: 15566290
[TBL] [Abstract][Full Text] [Related]
19. [Partially hydrogenated aryl-1,2/1,4-anthraquinone derivatives, 5-lipoxygenase inhibitors with arotinoid structure].
Wurm G; Probst R; Schwandt S
Pharmazie; 2001 Jul; 56(7):527-33. PubMed ID: 11487969
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of COX inhibitors against beta-amyloid-induced neurotoxicity in human neuroblastoma cells.
Ferrera P; Arias C
Neurochem Int; 2005 Dec; 47(8):589-96. PubMed ID: 16169124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
